Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Mipholate-S Tablet

Prescription Icon
Prescription Required

Marketer

Care Formulation Labs Pvt Ltd

Salt Composition

Mycophenolate sodium (360mg)

Overview Mipholate-S Tablet

Leflunomide tablets, classified as an immunosuppressant, are prescribed alongside other medications to prevent organ rejection following transplantation (kidney, heart, liver, etc.). Their mechanism involves suppressing the immune system to minimize attacks on the transplanted organ. Dosage varies based on the transplant type; adhere strictly to your physician's instructions. This medication can be ingested with or without food; swallow whole—do not crush, chew, or break. Consistent use maximizes effectiveness; continued use is crucial, even during periods of wellness, to prevent organ rejection. Treatment duration is determined by the need to prevent rejection. Common side effects include nausea, vomiting, diarrhea, abdominal pain, headache, hypertension, and alterations in white blood cell counts. Immunosuppression increases infection susceptibility and the risk of certain cancers. Numerous potential side effects exist; discuss these thoroughly with your doctor, noting any concerning symptoms requiring immediate medical attention. This medication is contraindicated during pregnancy, pregnancy planning, and breastfeeding due to the risk of birth defects and miscarriage. Consult your doctor before commencing treatment if you exhibit signs of infection, unusual bleeding or bruising, or have a history of digestive problems. Complete disclosure of all other medications is vital due to potential interactions affecting efficacy. Regular blood tests monitor blood cell counts; report any unexplained bruising or bleeding, sore throat, mouth sores, or fever immediately to your physician.

Primary Ingredients of Mipholate-S Tablet

There is no text provided to rewrite. Please provide the text you wish to be rephrased.

Uses of Mipholate-S Tablet

Avert organ rejection in transplant recipients.

Major Benefits of Mipholate-S Tablet:

Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Mipholate-S Tablets can be administered with or without food, however, consistent timing is recommended.

Common Side effects of Mipholate-S Tablet:

  • Nausea
  • Vomiting
  • Diarrhea
  • Abdominal pain
  • Headache
  • High blood pressure
  • Decreased white blood cell count (neutrophils)
  • Bacterial infection
  • Fungal infection
  • Pneumonia
  • Increased uric acid level in blood
  • Electrolyte imbalance
  • Anxiety
  • Breathlessness
  • Increased creatinine level in blood
  • Anemia (low number of red blood cells)
  • Acne
  • Muscle pain

How to use Mipholate-S Tablet:

Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Mipholate-S Tablets can be administered with or without food, although consistent timing is recommended.

How Mipholate-S Tablet works:

Mycophenolate mofetil tablets function as an immunosuppressant medication, dampening the body's immune response to minimize the risk of transplant rejection.

SAFETY ADVICE

AlcoholAlcoholSAFE

There are no known adverse interactions between Mipholate-S Tablet and alcohol consumption.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Mipholate-S Tablets is contraindicated during pregnancy due to established risks to the fetus. In exceptional life-threatening circumstances, a physician may consider its use if the potential benefits outweigh the known hazards. Physician consultation is recommended.

Breast feedingBreast feedingUNSAFE

The use of Mipholate-S Tablets is contraindicated while breastfeeding due to the potential for infant toxicity.

DrivingDrivingSAFE

Driving ability is typically unaffected by Mipholate-S Tablet.

KidneyKidneyCAUTION

Patients with severe renal impairment should use Myfortic tablets cautiously, as dose modification may be necessary. Physician consultation is advised.

LiverLiverSAFE IF PRESCRIBED

The use of Mipholate-S tablets in individuals with hepatic impairment appears to present a low risk. Current evidence indicates dose modification may not be necessary, though more data is desirable. Physician consultation is recommended.

What if you forget to take Mipholate-S Tablet :

Should you forget a Mipholate-S Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Mipholate-S Tablet

LabelValue
Chemical Category Phthalide-based compound
Developing Habits No.
Treatment Category Cancer Medications
Active Class Purine analog immunosuppressants

FAQs on Mipholate-S Tablet

Mipholate-S Tablets are immunosuppressants prescribed to help your body accept a donated kidney. They achieve this by suppressing your immune system's rejection of the foreign organ.
Mipholate-S Tablets may increase your risk of skin cancer and lymphoma. Minimize sun exposure by wearing protective clothing and sunscreen when outdoors. Contact your doctor immediately if you develop any new skin lesions, changes in existing moles, unusual sores, skin changes that don't heal, unexplained fever, persistent fatigue, weight loss, or swollen lymph nodes (neck, groin, or armpits).
Mipholate-S Tablets are neither steroids nor chemotherapy drugs; they're immunosuppressants that weaken the immune system to prevent organ rejection. Hair loss is a frequent side effect.
To monitor your blood count, kidneys, and liver function—which can be affected by Mipholate-S Tablets—your doctor will order blood tests before and during treatment. Regular blood tests help track your response to the medication and detect any side effects.
Mipholate-S tablets suppress your immune system. Because your immunity is already compromised, exposure to chickenpox or shingles poses a higher risk of infection. Your doctor's cautionary advice is therefore crucial. Contact your doctor immediately if you develop either illness, as specific treatment may be necessary.
Avoid Mipholate-S Tablet if pregnant or planning pregnancy. First-trimester use carries a high risk of miscarriage and birth defects. Therefore, use two reliable forms of contraception concurrently for four weeks before, throughout treatment, and for six weeks after stopping Mipholate-S Tablet. Your doctor will recommend suitable methods. Note that Mipholate-S Tablet can reduce birth control pill effectiveness; a second form of contraception is essential.
Reliable contraception should be used by either the man or his partner throughout treatment and for 90 days afterward. Men should refrain from donating semen during and for 90 days after stopping Mipholate-S Tablet treatment.
Mipholate-S Tablet
718
MRP 875
17% off